Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.
- DOI
- 10.1016/j.bmc.2016.12.014
- Published
- 2016-12-09
- Container
- Bioorg Med Chem
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.bmc.2016.12.014,
title = {Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.},
author = {Wu W and Chordia MD and Hart BP and Kumarasinghe ES and Ji MK and Bhargava A and Lawlor MW and Shin JY and Sera F and Homma S and Muchir A and Khire UR and Worman HJ.},
year = {2017},
journal = {Bioorg Med Chem},
doi = {10.1016/j.bmc.2016.12.014},
url = {https://doi.org/10.1016/j.bmc.2016.12.014}
}RIS
TY - JOUR TI - Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation. AU - Wu W AU - Chordia MD AU - Hart BP AU - Kumarasinghe ES AU - Ji MK AU - Bhargava A AU - Lawlor MW AU - Shin JY AU - Sera F AU - Homma S AU - Muchir A AU - Khire UR AU - Worman HJ. PY - 2017 JO - Bioorg Med Chem DO - 10.1016/j.bmc.2016.12.014 UR - https://doi.org/10.1016/j.bmc.2016.12.014 ER -
APA
W, W., MD, C., BP, H., ES, K., MK, J., A, B., MW, L., JY, S., F, S., S, H., A, M., UR, K., & HJ., W. (2017). Macrocyclic MEK1/2 inhibitor with efficacy in a mouse model of cardiomyopathy caused by lamin A/C gene mutation.. Bioorg Med Chem. https://doi.org/10.1016/j.bmc.2016.12.014
Source records
- europe-pmc · retrieved 2026-09-26T19:07:11.670Z